
SFPI-FPIM
Description
The Federal Holding and Investment Company (SFPI-FPIM) serves as the sovereign wealth fund of Belgium, wholly owned by the Belgian State. Established with the core mission to support Belgian economic growth and stability, SFPI-FPIM manages federal participations in both public and private enterprises. It acts as a crucial financial instrument, channeling investments into key sectors to foster innovation, job creation, and sustainable development across the nation. Its strategic mandate positions it as a long-term partner for companies aligned with Belgium's economic priorities.
SFPI-FPIM's investment strategy is broad yet focused, targeting sectors deemed vital for Belgium's future competitiveness. These include life sciences, digital technologies, energy transition, the circular economy, mobility solutions, and deep tech. The entity's substantial financial capacity is evidenced by its assets under management, which stood at approximately €17.5 billion (around $18.9 billion USD) as of 2022. This significant capital base allows SFPI-FPIM to engage in diverse investment activities, ranging from venture capital to strategic participations in larger enterprises, all aimed at strengthening the Belgian economic fabric.
To execute its investment mandate, SFPI-FPIM operates through specialized funds and direct strategic investments. Its "Growth & Transition Fund" typically provides equity and quasi-equity financing, with investment tickets generally ranging from €1 million to €15 million, supporting the expansion and transformation of established Belgian companies. Concurrently, the "Life Sciences & Deep Tech Fund" focuses on innovative early to mid-stage companies, offering financing from €500,000 to €5 million to accelerate research, development, and commercialization in these high-potential fields. Through these targeted approaches, SFPI-FPIM plays a pivotal role in nurturing promising ventures and ensuring Belgium's continued economic prosperity.
Investor Profile
SFPI-FPIM has backed more than 39 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 15% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in Belgium, United States, The Netherlands.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $540K – $16.2M.
Stage Focus
- Series B (28%)
- Series Unknown (23%)
- Series A (15%)
- Series C (13%)
- Series D (13%)
- Private Equity (3%)
- Series E (3%)
- Undisclosed (3%)
Country Focus
- Belgium (72%)
- United States (10%)
- The Netherlands (8%)
- France (5%)
- Spain (3%)
- Switzerland (3%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Manufacturing
- Medical Device
- Pharmaceutical
- Therapeutics
- Health Diagnostics
- Information Technology
- Personal Health
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.